Millipore Sigma Vibrant Logo

385920 HSP90 Inhibitor, CCT018159 - CAS 171009-07-7 - Calbiochem

The HSP90 Inhibitor, CCT018159, also referenced under CAS 171009-07-7, controls the biological activity of HSP90.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: 4-(4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-methyl-1H-pyrazol-3-yl)-6-ethylresorcinol

View Products on Sigmaaldrich.com
385920
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
171009-07-7C₂₀H₂₀N₂O₄

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
385920-5MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 5 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewA cell-permeable pyrazoloresorcinol compound that inhibits HSP90 ATPase activity (IC50 = 3.2 µM and 6.6 µM against human HSP90β and yeast HSP90, respectively) by targeting the enzyme's N-terminal ATP binding site. It exhibits no detectable effects against human Hsp70 or topoisomerase II even at concentrations as high as 100 µM and inhibits a panel of 20 commonly studied kinases only at much higher concentrations. Unlike 17-AAG (Cat. No. 100068), the antitumor activity of CCT018159 is not affected by the expression of NQ01/DT-diaphorase or P-glycoprotein.
      Catalogue Number385920
      Brand Family Calbiochem®
      Synonyms4-(4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-methyl-1H-pyrazol-3-yl)-6-ethylresorcinol
      References
      ReferencesHardcastle, A., et al. 2007. Mol. Cancer Ther. 6, 1112.
      Sharp, S.Y., et al. 2007. Cancer Res. 67, 2206.
      Smith, N.F., et al. 2006. Mol. Cancer Ther. 5, 1628.
      Dymock, B.W., et al. 2005. J. Med. Chem. 48, 4212.
      Cheung, K.M., et al. 2005. Bioorg. Med. Chem. Lett. 15, 3338.
      Product Information
      CAS number171009-07-7
      FormWhite solid
      Hill FormulaC₂₀H₂₀N₂O₄
      Chemical formulaC₂₀H₂₀N₂O₄
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/37/38

      Irritating to eyes, respiratory system and skin.
      S PhraseS: 24/25-36/37/39

      Avoid contact with skin and eyes.
      Wear suitable protective clothing, gloves and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solution are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      385920-5MG 04055977189841

      Documentation

      HSP90 Inhibitor, CCT018159 - CAS 171009-07-7 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      HSP90 Inhibitor, CCT018159 - CAS 171009-07-7 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      385920

      Referencias bibliográficas

      Visión general referencias
      Hardcastle, A., et al. 2007. Mol. Cancer Ther. 6, 1112.
      Sharp, S.Y., et al. 2007. Cancer Res. 67, 2206.
      Smith, N.F., et al. 2006. Mol. Cancer Ther. 5, 1628.
      Dymock, B.W., et al. 2005. J. Med. Chem. 48, 4212.
      Cheung, K.M., et al. 2005. Bioorg. Med. Chem. Lett. 15, 3338.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-March-2008 JSW
      Synonyms4-(4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-methyl-1H-pyrazol-3-yl)-6-ethylresorcinol
      DescriptionA cell-permeable pyrazoloresorcinol compound that inhibits HSP90 ATPase activity (IC50 = 3.2 µM and 6.6 µM against human HSP90β and yeast HSP90, respectively) by targeting the enzyme's N-terminal ATP binding site. It exhibits no detectable effects against human Hsp70 or topoisomerase II even at concentrations as high as 100 µM and inhibits a panel of 20 commonly studied kinases only at much higher concentrations. Unlike 17-AAG (Cat. No. 100068), the antitumor activity of CCT018159 is not affected by the expression of NQ01/DT-diaphorase or P-glycoprotein.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number171009-07-7
      Chemical formulaC₂₀H₂₀N₂O₄
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (35 mg/ml), H₂O (1.7 mg/ml) or Ethanol (35 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solution are stable for up to 3 months at -20°C.
      Toxicity Irritant
      ReferencesHardcastle, A., et al. 2007. Mol. Cancer Ther. 6, 1112.
      Sharp, S.Y., et al. 2007. Cancer Res. 67, 2206.
      Smith, N.F., et al. 2006. Mol. Cancer Ther. 5, 1628.
      Dymock, B.W., et al. 2005. J. Med. Chem. 48, 4212.
      Cheung, K.M., et al. 2005. Bioorg. Med. Chem. Lett. 15, 3338.